MedTrace Logo

Cardiovascular Risk Markers in Polycystic Ovary Syndrome (PCOS)

NCT01195168 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 201

Last updated 2010-09-06

No results posted yet for this study

Summary

Women with polycystic ovary syndrome (PCOS) are more often overweight or obese and are more insulin resistant than women without the condition and may be at greater risk of developing cardiovascular disease. It is not know whether it is the overweight and insulin resistant component of PCOS, or PCOS per se which leads to the greater cardiovascular disease risk. The aim of this study was to examine cardiovascular risk markers in women with PCOS versus a control population matched for body mass index (BMI), and or, insulin resistance

Conditions

  • Polycystic Ovary Syndrome

Sponsors & Collaborators

  • University College Dublin

    collaborator OTHER

  • The Adelaide and Meath Hospital

    lead OTHER

Principal Investigators

  • James Gibney, Dr · The Adelaide and Meath Hospital

  • Helen M Roche, Prof · University College Dublin

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-11-30
Primary Completion
2008-07-31
Completion
2008-07-31

Countries

  • Ireland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01195168 on ClinicalTrials.gov